Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
J&J’s Duato Makes 358 Times His Median Employee; Vertex CEO Makes Just 80 Times
Johnson & Johnson chief Joaquin Duato earned $32.6 million in 2025, creating a 358‑to‑1 pay ratio with the median employee who earned $91,000—the widest gap among the ten pharma firms studied. Eli Lilly’s David Ricks followed with a $36.7 million package and a 293‑to‑1 ratio, while Vertex’s Reshma Kewalramani posted the lowest ratio at 80‑to‑1 thanks to a median staff salary of $264,487. Across pharma, CEO compensation averaged $29.4 million, 23 % higher than the prior year, dwarfing the U.S. average worker wage of $69,846.
When Algorithms Decide Who Gets Health Care
Law professor Jennifer D. Oliva warns that AI‑powered coverage algorithms used by insurers to approve, deny, or limit care operate without FDA‑type safety testing. Her analysis shows that nearly one‑in‑five insured Americans experience claim denials, with 82% of physicians observing...
Financial Incentives, over Diagnosis, and Weak Oversight: Autism Claims Are Driving up Medicare Costs
A recent analysis reveals that Medicaid spending on applied behavior analysis (ABA) therapy for autism has exploded, rising 561% to over $2.2 billion across eight states. The surge is driven by massive overdiagnosis, with prevalence estimates inflating from 1 in 150...
Dr Louise Irvine: Setting up a Medical Advisory Network
Dr. Louise Irvine explains how she helped establish CanSG, a multidisciplinary clinical advisory network focused on sex‑related health issues, particularly the controversial use of puberty blockers and gender‑affirming treatments for youth. She outlines the group's origins in the UK, its...
Addus CEO: Moratorium Has Little To No Impact On Growth, Valuations
Addus HomeCare CEO Dirk Allison told investors that the CMS‑imposed moratorium on new home‑health Medicare enrollments will not hinder the company’s growth strategy. Because the freeze targets only home health and hospice, Addus’s personal care services segment remains untouched, allowing...
AI‑crafted Sensors Promise Earlier Cancer Detection
#AI-generated #Sensors open new paths for early cancer detection by Anne Trafton @MIT Learn more: https://t.co/udkbd5V4cP #MedTech #Healthcare #HealthTech #Tech #TechForGood https://t.co/6EWRhwCIGA
NHS Launches £900m AI Framework
The NHS Shared Business Services (NHS SBS) has issued a call for suppliers to join a new £900 million (≈ $1.15 billion) artificial‑intelligence framework that will run from May 2027 to May 2035. The eight‑year, eight‑lot open framework covers radiology and diagnostic imaging, early detection,...
Sinai Health Partners with Unity Health on Epic
Sinai Health announced it will adopt Unity Health’s Epic electronic patient record (EPR) system, extending a shared digital platform across two major Toronto academic hospitals. The move follows Ontario’s 2025 directive urging hospitals to consolidate into province‑wide EPR environments, accelerating...
Reduce Length of Stay by Eliminating Hidden Delays
Hospitals often track length of stay, bed turnover and patient throughput, but hidden coordination failures—delayed consults, inefficient transfers, fragmented handoffs—drive hidden inefficiencies. Hypercare’s upcoming webinar will dissect where these breakdowns occur across departments and care transitions. Speakers include Dr. Karim...
CareChain Helps Assess MSK Patients Earlier
The McGill University Health Centre (MUHC) is piloting CareChain, a digital platform from MultiCIM Technologies, to help physiotherapists conduct advanced musculoskeletal (MSK) assessments and triage patients who may need surgery. By standardising data collection and decision‑making, the tool aims to...
Leadless, Dual-Chamber Pacemakers for NB Patients
New Brunswick’s Horizon Heart Centre has become the first site in Canada to implant Abbott’s AVEIR DR dual‑chamber leadless pacemaker. The system uses two tiny, battery‑powered units—one in the right atrium and one in the right ventricle—that communicate wirelessly to mimic...
Spinal Neuromotor Rehabilitation Using a Portable Isokinetic Training Robot
Researchers at Beihang University and MIT unveiled a 0.96‑kg wearable robot that provides isokinetic resistance training for juveniles with spinal muscular atrophy type II. In a six‑week clinical trial with six participants, the device produced a 7° improvement in sit‑to‑stand knee...
AI Tool Guides Doctors to Treat Newborn’s Rare Disease
How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’ An AI tool, Biomedical Data Translator, helped doctors at Mayo Clinic find a treatment for Jorie Kraus https://t.co/3qs1WIDquU
Dueling Memos Are a Case Study in the Politicization of Scientific Data
BioCentury has published a detailed cookie policy that classifies website cookies into five groups—strictly necessary, functional, marketing, advertising, and analytics. Each category explains its purpose, from enabling authentication to personalizing marketing messages, and clarifies that none store personally identifiable information....
Strategic Analysis of the ResMed and Oura Partnership: Bridging Consumer Wearables and Clinical Sleep Medicine
ResMed and Oura announced a strategic partnership that integrates the Oura Ring’s passive biometric monitoring with ResMed’s clinical software and referral network. The collaboration aims to close the diagnostic gap in obstructive sleep apnea, where roughly 80% of U.S. patients...
Forget the Search for a Single AI ROI Number, Say Akhter and Chou — Build Coalitions, Scale What Works
In this episode, Children’s Hospital of Philadelphia’s SVP, Chief Digital and Information Officer Shaqib Octor and veteran health‑IT executive David Chow discuss how health systems are grappling with defining AI ROI. They argue that ROI isn’t just a dollar figure—it...
Special Courts Helps Veterans Stay Out of Jail - but Staffing Losses at VA and Cuts to Government Programs Are...
Veterans Treatment Courts (VTCs) provide an alternative to incarceration for service members grappling with substance use, mental health issues, and homelessness, operating in more than 745 courthouses across the United States. They rely on dedicated VA clinicians and federal funding—tens...
Aid Cuts Fuel DRC Ebola Surge, Hindering Control
NEW: The Trump admin's foreign aid cuts have hampered infection control in the DRC as the country's Ebola outbreak grows, people involved across the region tell me https://t.co/BpAnbXcsYh
Brain Connectivity Predicts How Well Antidepressants Work Compared to Placebos
Researchers re‑analyzed a sertraline versus placebo trial in major depressive disorder using a data‑driven symptom model. They discovered that both drug and placebo follow the same geometric path of mood improvement, but sertraline pushes patients farther along that trajectory, especially...
Financial Toxicity Negatively Impacts Adherence to Imaging Recommendations
A new study in Academic Radiology surveyed 399 parents at two U.S. pediatric hospitals and found that financial toxicity is a major barrier to following imaging recommendations. The average FACIT‑COST score was 24.6, with nearly half of respondents classified as...
/file/attachments/2990/6I1A7348_535592_427689.jpg)
CRISIS AVERTED: Reprieve for Talisman Foundation as Eviction Halted After Health Minister Motsoaledi Intervenes
South Africa’s Health Minister Aaron Motsoaledi intervened to halt the eviction of the Talisman Foundation, a 200‑bed psychosocial rehabilitation centre in Johannesburg, for three months. The eviction threat had sparked fears of a repeat of the 2016 Life Esidimeni tragedy, prompting...
/file/attachments/orphans/ED_5195951_890060.jpg)
NATIONAL HEALTH INSURANCE: Department of Health Mulls over New Licence Approach After Constitutional Court Ruling
South Africa's Constitutional Court struck down the controversial "certificate of need" provision that would have let the government dictate where doctors and nurses could work. The Department of Health now says it will explore alternative licensing schemes modeled on Canada...
America Built An Ebola Response System After 2014. Here’s How It Works
An American physician treating patients in the Democratic Republic of Congo contracted the rare Bundibugyo strain of Ebola and was evacuated to Germany, prompting a rapid U.S. public‑health response. The Centers for Disease Control and Prevention activated travel restrictions, screening...
STAT+: Virginia Governor Vetoes Legislation to Create an Advisory Panel to Lower the Cost of Prescription Drugs
Virginia Governor Abigail Spanberger vetoed HB 483, a bill that would have created a state advisory panel to lower prescription drug costs by using Medicare’s drug list as a benchmark and setting upper payment limits. The proposal would have made Virginia...
The Menopause Impact Scale: A Modern Tool for Perimenopause Symptom Evaluation and Clinical Care
Oura has introduced the Menopause Impact Scale (MIS), a scientifically‑validated patient‑reported outcomes survey that measures the quality‑of‑life impact of 22 perimenopause and post‑menopause symptoms. Unlike legacy tools that focus only on symptom frequency or severity, MIS scores each symptom’s effect...
White House Announces Expansion of TrumpRx.gov
The White House announced an expansion of TrumpRx.gov, the federal prescription‑discount program launched under the Trump administration. The rollout adds roughly 200 new brand‑name and generic drugs and widens eligibility to all Medicare Part D beneficiaries, not just seniors on low...
WHO Declares Ebola Global Health Emergency: 6 Things to Know
The World Health Organization on May 17, 2026 declared the Ebola outbreak in the Democratic Republic of the Congo and Uganda a public health emergency of international concern. Health authorities report at least 500 suspected cases, 130 suspected deaths, 30...
Blood Test Measuring Biological Age May Reveal Dementia Risk
Researchers at King’s College London validated a blood‑based metabolomic aging clock that can flag individuals at heightened risk of dementia years before symptoms appear. Participants whose biological age exceeded their chronological age by more than one standard deviation faced a...
Analysis Finds Marketplace Enrollment Could Fall by at Least 17% in 2026
An analysis released this week projects that enrollment in the Affordable Care Act’s health insurance marketplaces will decline by at least 17% by 2026, compared with current levels. The forecast attributes the drop to rising premiums, the phasing out of...
Merck and Kelun‑Biotech’s Sac‑TMT ADC Cuts Death Risk in Phase III Endometrial Cancer Trial
Merck and China‑based Kelun‑Biotech announced that their TROP2‑directed ADC sacituzumab tirumotecan (sac‑TMT) met primary endpoints in the TroFuse‑005 Phase III trial, delivering statistically significant overall‑survival and progression‑free‑survival improvements versus physician‑chosen chemotherapy in 776 patients with advanced or recurrent endometrial cancer. The...
BIOTRONIK, Charité and German Heart Center Foundation Unite to Advance Digital Cardiology
BIOTRONIK, Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation announced a research partnership to accelerate digital cardiology. The collaboration will create AI‑based tools, simulation environments, and an endowed professorship, positioning Berlin as Europe’s digital heart‑care hub.
As Doctor Shortage Rages On, Physician Assistant Pay Hits $140,000
The American Academy of Physician Associates reports median total compensation for physician assistants (PAs) rose 4.5% to $140,000 in 2025, up from $134,000 in 2024, with 58% receiving a median bonus of $6,000. The National Commission on Certification of Physician...
GeoVax Labs Raises $3 Million Private Placement, Emphasizes MVA Platform for Pandemic Preparedness
GeoVax Labs announced a $3 million private placement on May 19, 2026, and used the filing to stress the strategic value of its Modified Vaccinia Ankara (MVA) platform for rapid, scalable vaccine responses to emerging infectious threats. The financing will back ongoing development...
Startup Creates Embryos Using Lab-Grown Sperm
Paterna Biosciences announced it has successfully generated human sperm cells from stem cells in the laboratory and used them to fertilize oocytes, producing embryos. The breakthrough was demonstrated by co‑founder and CEO Dr. Alex Pastuszak, who explained the step‑by‑step protocol...
Takeda Engaged in Antitrust Scheme to Delay Generic Constipation Drug: US Jury
A Boston federal jury found Takeda Pharmaceutical liable for an antitrust scheme that delayed the generic version of its constipation drug Amitiza, awarding roughly $885 million in damages. The award could triple under federal law, potentially reaching $2.47 billion. The case centers...
TrumpRx Adds Hundreds of Generic Medicines to Site
The Trump administration’s direct‑to‑consumer pharmacy, TrumpRx, announced the addition of more than 600 generic medicines to its online catalog. The expansion more than doubles the platform’s drug inventory, positioning it as a broader alternative to traditional pharmacy benefit managers. TrumpRx...
Telehealth Company Launches Direct-to-Consumer Imaging Order Service
Diagnostic Orders Direct, a Las Vegas telehealth platform, launched a direct‑to‑consumer imaging and lab ordering service across 30 states. For a flat $40 fee, patients receive a virtual consultation with a licensed clinician who assesses symptom history and determines test...
New Shell Helps Gold Nanoparticles Keep Shape Under Laser Heat Longer
Researchers from Córdoba, Strasbourg and the Sorbonne have developed a polymer‑based shell that preserves the distinctive bipyramidal shape of gold nanoparticles during laser‑induced heating. The protective layer outperforms traditional sodium citrate ligands, keeping the particles stable longer and maintaining their...
Another Paragon Offshoot Chooses Reverse Merger, This Time for Migraine Drugs
Paragon Therapeutics’ latest spin‑off, InMed Pharmaceuticals, has merged with Mentari Therapeutics through a reverse merger, creating a publicly traded company focused on migraine prevention drugs. The deal, announced on Tuesday, combines InMed’s CGRP‑targeting pipeline with Mentari’s clinical assets and injects...
Greek Courts Deliver Landmark Justice: State Held Liable for COVID Shot Harms
Greek administrative courts have begun holding the Hellenic Republic liable for COVID‑19 vaccine injuries, ordering $324,000 in compensation to a family after a woman died from AstraZeneca‑induced thrombosis with thrombocytopenia syndrome (TTS). The decision builds on a 2025 ruling that...
Sustained Therapeutics – Presents Positive Phase 2 Data for ST-01 in Podium Presentation at the American Urological Association 2026 Annual...
Sustained Therapeutics presented Phase 2 data showing its ST‑01 polymer‑lidocaine formulation significantly reduced pain in men with chronic scrotal content pain (CSCP). At the 70 mg/mL dose, 67% of patients achieved a ≥2‑point pain reduction and 83% met clinical response criteria, far...
Q&A: Advocate Health CNIO on AI Implementation Best Practices for Nursing
Advocate Health’s chief nursing informatics officer outlines how ambient AI documentation is being rolled out to cut nursing clicks and reduce documentation fatigue. A pilot showed 65% of caregivers used the tool six or more times per shift, with more...
Northwestern Medicine's Journey in Scaling Up the Collaborative Care Model
Northwestern Medicine has scaled its Collaborative Care Model to all 70 primary‑care clinics, reaching roughly 500 physicians. The effort began with mandatory depression screening a decade ago and grew through a partnership with the Department of Psychiatry and West Health’s...
HopeHealth’s New Academic Partnership a ‘Nexus’ of Hospice Leader Development
HopeHealth has formalized an academic practice partnership with the University of Rhode Island’s College of Nursing to expand hospice and palliative‑care training. The collaboration provides nursing students with advanced clinical rotations, research opportunities for doctoral candidates, and guest lectures from...
New York Governor Signs Bills To Preserve Mandatory Vaccines
New York Governor Kathy Hochul signed two bills that separate the state’s vaccine requirements from federal approval, mandating that children receive shots such as measles and hepatitis B based on New York health‑commissioner guidance. The legislation also obligates health insurers to...
Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs
The Trump administration has broadened TrumpRx to include more than 600 generic drugs for chronic illnesses such as diabetes, hypertension and high cholesterol. The platform now integrates price‑comparison tools and links with Cost Plus Drugs, Amazon Pharmacy and GoodRx, letting cash‑pay patients...
Memphis Launches 24/7 Children’s Wellness Center to Combat Youth Mental‑Health Crisis
Alliance Healthcare Services inaugurated a 24/7 Children’s Wellness Center in Memphis’s Binghampton neighborhood, opening June 1 to serve kids aged 4‑17. The $34 million campus, backed by state leaders, seeks to address rising youth mental‑health emergencies and keep children out of the...
Ozempic Gains First Australian Approval for Heart‑Disease Treatment
Australia’s Therapeutic Goods Administration has approved semaglutide, sold as Ozempic, for the treatment of established cardiovascular disease, marking the nation’s first indication beyond diabetes. The decision follows the Heart Foundation’s new Clinical Consensus Statement and a recommendation by the Pharmaceutical...
Full-Life Technologies Secures $150 Million Series D to Scale Radiotherapeutics Platform
Full-Life Technologies closed a $150 million financing package—$110 million in Series D equity and $40 million in debt—led by Vivo Capital and a slate of strategic investors. The capital will accelerate its alpha‑emitting radiotherapeutics pipeline and bring a GMP‑grade manufacturing site in Belgium online,...
FDA Clears Genentech’s Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer Therapy
Genentech announced FDA approval of Tecentriq and Tecentriq Hybreza as adjuvant therapy for muscle‑invasive bladder cancer patients with ctDNA‑detected minimal residual disease. The Phase III IMvigor011 trial showed a 36% drop in disease recurrence or death and a 41% reduction in...